Similarly, the outcomes of subgroup analyses revealed that anti-MDA5 antibody had a good diagnostic accuracy for RPILD in DM patients (sensitivity > 0.80, specificity > 0.80). The gene discussed is IFIH1; the disease is dermatomyositis.